In this study, we aimed to confirm that C1orf131 is overexpressed in various cancers, such as LUAD, liver hepatocellular carcinoma (LIHC), lymphoid neoplasm, and bladder urothelial carcinoma (BLCA) from TCGA database. This evidence concerns the gene FSAF1 and bladder transitional cell carcinoma.